Lv1
50 积分 2025-06-06 加入
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
3天前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
3天前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
10天前
已完结
Oral IL-23-blocking peptide racks up phase III wins in inflammatory disease
1个月前
已完结
Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
Transcriptional code for circuit integration in the injured brain by transplanted human neurons
1个月前
已关闭
Co-opting signalling molecules enables logic-gated control of CAR T cells
2个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
2个月前
已完结
皖公网安备34019202002308
